och-ziff capital managemen-a
(OZM:New York)

Executive Profile*

Background*

Mr. Michael Leslie Cohen, BA serves as Senior Arbitrage Specialist of Och-Ziff Europe and helps manage its London office. He served as an Executive Managing Director at Och-Ziff Capital Management Group LLC. Mr. Cohen served as Head of European Investing at Och-Ziff Capital Management Group LLC until March 18, 2013. Mr. Cohen joined Och-Ziff in 1997 and assists in the management of Och-Ziff's London office. He served as Chief Executive Officer of Xceed Molecular, Inc. ... (formerly, MetriGenix, Inc.) since June 7, 2005. He served as the President and Chief Operating Officer of GeneXP Biosciences Inc. He was a Vice President and Partner at Mercer Management Consulting, where he advised senior executives on strategic, operational, and organizational effectiveness. He served as Head of European Merger Arbitrage and Event Driven Investing at Och-Ziff Capital Management Group LLC. Mr. Cohen served as Managing Partner and Research Analyst of Och-Ziff Capital Management Group LLC. He joined Och-Ziff in 1997. He served as a Equity Research Analyst of Franklin Mutual Advisory, analyzing equity and debt investments and an Investment Banking Analyst of CS First Boston, specializing in the financial services sector. He was an Executive at CVC Capital Partners Ltd. Mr. Cohen has been Non Executive Chairman of Xceed Molecular, Inc. since February 1, 2007. He served as a Non-Executive Director of Ophir Energy Plc from March 17, 2008 to July 7, 2011. He serves as a Director of GeneXP Biosciences Inc. He serves on the Boards of NSI and APX, both Heritage Partners portfolio companies. He is a Trustee of the Dibner Institute at MIT, and of the Dibner Fund-a philanthropic organization. Mr. Cohen holds BA in Economics from Bowdoin College.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
OZM:US	$10.91 USD	-0.08

COMPETITOR COMPENSATION